Clincosm LogoSign in Get a demo

Computer-based Skin Aging Simulation for Skin Cancer Prevention

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Completed
CT.gov ID
NCT04532437
Collaborator
(none)
60
Enrollment
1
Location
1.2
Actual Duration (Months)
48.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.

Condition or Disease Intervention/Treatment Phase
  • Other: artificial intelligence-based skin aging simulation
  • Other: electronic questionnaire 1
  • Other: electronic questionnaire 2

Detailed Description

In young adulthood an increasing UV-exposure often starts because of the belief that tanning increases attractiveness]. Raising awareness and educating students and adults regarding practices for skin cancer prevention are critical since skin cancer is increasing rapidly worldwide. Skin cancer preventive interventions for adolescents are needed to improve their motivation for sun safety behavior. This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Computer-based Skin Aging Simulation for Skin Cancer Prevention: A Pilot Study
Actual Study Start Date :
Feb 9, 2021
Actual Primary Completion Date :
Mar 19, 2021
Actual Study Completion Date :
Mar 19, 2021

Outcome Measures

Primary Outcome Measures

  1. Change in visual analogue scale (VAS) score regarding importance of UV- protection [before and after the skin aging simulation (each scoring session will take about 15-20 minutes)]

    Change in VAS score regarding importance of UV- protection (0 = not important; 10 = extremly important)

  2. Change in VAS score regarding rating of personal exposure to UV radiation [before and after the skin aging simulation (each scoring session will take about 15-20 minutes)]

    Change in VAS score regarding rating of personal exposure to UV radiation (0 = no exposure; 10 = very high exposure)

Secondary Outcome Measures

  1. Questionnaire asking for reduction of UV- exposure (yes/no) [after the skin aging simulation (each scoring session will take about 15-20 minutes)]

    Questionnaire asking for reduction of UV- exposure (yes/no)

  2. Questionnaire asking for intensification of UV protection measures (yes/ no) [after the skin aging simulation (each scoring session will take about 15-20 minutes)]

    Questionnaire asking for intensification of UV protection measures (yes/ no)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • healthy female volunteers

  • written,Institutional Review Board (IRB)/ Independent Ethics Committee (IEC)-approved informed consent.

Exclusion Criteria:
  • skin diseases requiring medical therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Dermatology, University Hospital Basel Basel Switzerland 4031

Sponsors and Collaborators

  • University Hospital, Basel, Switzerland

Investigators

  • Principal Investigator: Lara Valeska Maul, Dr. med., Department of Dermatology, University Hospital Basel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT04532437
Other Study ID Numbers:
  • Req-2020-00963; sp20Maul3
First Posted:
Aug 31, 2020
Last Update Posted:
Dec 15, 2021
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Basel, Switzerland
skin cancer prevention
skin aging simulation
UV-exposure
skin analysis photo system
VISIA® photo analysis system
Additional relevant MeSH terms:
Skin Neoplasms

Study Results

No Results Posted as of Dec 15, 2021